Ascendis Pharma A/S
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.About ASND
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs.
ASND Key Statistics
Stock Snapshot
With a market cap of 14.78B, Ascendis Pharma A/S(ASND) trades at $225.25. The stock has a price-to-earnings ratio of 16.37.
As of 2026-10-18, Ascendis Pharma A/S(ASND) stock has fluctuated between $223.78 and $226.63. The current price stands at $225.25, placing the stock +0.7% above today's low and -0.6% off the high.
The Ascendis Pharma A/S(ASND)'s current trading volume is 673.66K, compared to an average daily volume of 777.58K.
During the past year, Ascendis Pharma A/S(ASND) stock moved between $186.05 at its lowest and $282.15 at its peak.
During the past year, Ascendis Pharma A/S(ASND) stock moved between $186.05 at its lowest and $282.15 at its peak.
ASND News
...
Ascendis Pharma (ASND) announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, has adopted an opin...
UBS assumed coverage of Ascendis Pharma (ASND) with a Buy rating with a price target of $269, down from $307. The company’s key drug, Yorvipath for chronic hypo...
Analyst ratings
100%
of 22 ratingsMore ASND News
An update from Ascendis Pharma ( (ASND) ) is now available. On October 13, 2026, Ascendis Pharma’s board granted 35,890 new employee warrants, each convertible...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.